3-48268348-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016089.3(ZNF589):āc.657G>Cā(p.Glu219Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,614,212 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016089.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF589 | NM_016089.3 | c.657G>C | p.Glu219Asp | missense_variant | 4/4 | ENST00000354698.8 | NP_057173.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF589 | ENST00000354698.8 | c.657G>C | p.Glu219Asp | missense_variant | 4/4 | 1 | NM_016089.3 | ENSP00000346729.3 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152230Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000440 AC: 11AN: 250220Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135716
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461864Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727228
GnomAD4 genome AF: 0.000158 AC: 24AN: 152348Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74504
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.657G>C (p.E219D) alteration is located in exon 4 (coding exon 4) of the ZNF589 gene. This alteration results from a G to C substitution at nucleotide position 657, causing the glutamic acid (E) at amino acid position 219 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at